MAPK3 and lung carcinoma: SQS induced the phosphorylation of Src, ERK1/2, and AKT in lung cancer cell lines, but the levels of pSrc, pERK1/2, and MMP1 were decreased after treatment with SKI (Src inhibitor) (Fig. 4c, f).